Saturday, April 22, 2006 7:51:55 AM
alterboy4,I will !! Its a "patent of association" its a premise of assocation. The market will respond if history has showed a direct relationship between 2 or more points.
If the history of patents and product approval and revenue have showed a direct relationship to each other with a high degree of success from companys around the world than you would see the market respond in a very strong way.
The market has in fact responded to this patent news.It has responded with "no responce" because history has showed that there are in fact countless companys around the world who own countless numbers of patents and have in fact done nothing with them. There is no direct relationship between a patent approval and product approval. There is no direct relationship between a patent approval and revenue.There is no rleationship between the 2 only a in direct relationship and for the market "THATS NOT GOOD ENOUGHT" to many companys own patents and have done nothing with them. No progress 0- No Revenue - no Product means patents are worth Zero to the investor.
Dnag is going on 7 years come 2007 with their lead product Ovanome and for the last 3 years running clinical trials with Moffitt still on phase 1 with no progress. The market see this and knows about this story from other companys who did the same.It means "NO Market Responce" With out progress a patent may as well be toilet paper.
If the history of patents and product approval and revenue have showed a direct relationship to each other with a high degree of success from companys around the world than you would see the market respond in a very strong way.
The market has in fact responded to this patent news.It has responded with "no responce" because history has showed that there are in fact countless companys around the world who own countless numbers of patents and have in fact done nothing with them. There is no direct relationship between a patent approval and product approval. There is no direct relationship between a patent approval and revenue.There is no rleationship between the 2 only a in direct relationship and for the market "THATS NOT GOOD ENOUGHT" to many companys own patents and have done nothing with them. No progress 0- No Revenue - no Product means patents are worth Zero to the investor.
Dnag is going on 7 years come 2007 with their lead product Ovanome and for the last 3 years running clinical trials with Moffitt still on phase 1 with no progress. The market see this and knows about this story from other companys who did the same.It means "NO Market Responce" With out progress a patent may as well be toilet paper.
